Article
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Progress in neuro-psychopharmacology & biological psychiatry - 1 Jul 2013
Calati Raffaella, Crisafulli Concetta, Balestri Martina, Serretti Alessandro, Spina Edoardo, Calabrò Marco, Sidoti Antonina, Albani Diego, Massat Isabelle, Höfer Peter, Amital Daniela, Juven-Wetzler Alzbeta, Kasper Siegfried, Zohar Joseph, Souery Daniel, Montgomery Stuart, Mendlewicz Julien
Abstract excerpt
Treatment resistant depression (TRD) is a significant clinical and public health problem. Among others, neuroplasticity and inflammatory pathways seem to play a crucial role in the pathomechanisms of antidepressant efficacy. The primary aim of this study was to investigate whether a set of single nucleotide polymorphisms (SNPs) within two genes implicated in neuroplasticity and inflammatory processes (the mitogen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
